Goodwin Advises Repligen in Acquisition of BioLife Solutions for Approximately $1.5 Billion
July 22, 2026
July 22, 2026
BOSTON, Massachusetts, July 22 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises Repligen in Acquisition of BioLife Solutions for Approximately $1.5 Billion
*
The Life Sciences and Public M&A teams advised Repligen Corporation (NASDAQ: RGEN) ("Repligen"), a life sciences company focused on bioprocessing technology leadership, in its definitive agreement to acquire BioLife Sol . . .
* * *
Goodwin Advises Repligen in Acquisition of BioLife Solutions for Approximately $1.5 Billion
*
The Life Sciences and Public M&A teams advised Repligen Corporation (NASDAQ: RGEN) ("Repligen"), a life sciences company focused on bioprocessing technology leadership, in its definitive agreement to acquire BioLife Sol . . .